Eton Pharmaceuticals (ETON) Assets Average (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Assets Average data on file, last reported at $98.3 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 75.61% year-over-year to $98.3 million; the trailing twelve-month figure through Dec 2025 stood at $98.3 million (up 75.61% YoY), and the FY2025 full-year result was $84.1 million, up 55.97% from the prior year.
• Assets Average declined to $98.3 million in Q4 2025, from $103.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $103.1 million in Q3 2025 to a low of $22.3 million in Q3 2022.
• A 5-year average of $42.5 million and a median of $30.9 million in 2021 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slipped 24.31% in 2022 and soared 204.72% in 2025, its largest moves.
• Tracing ETON's Assets Average over 5 years: stood at $27.0 million in 2021, then decreased by 13.91% to $23.3 million in 2022, then jumped by 35.91% to $31.6 million in 2023, then soared by 76.97% to $56.0 million in 2024, then soared by 75.61% to $98.3 million in 2025.
• Business Quant data shows ETON's Assets Average at $98.3 million in Q4 2025, $103.1 million in Q3 2025, and $92.9 million in Q2 2025.